Study S003410

A Multiple-Dose Clinical Trial to Study the Effect of MK-8457 on Ambulatory Blood Pressure in Hypertensive Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01446003
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: TRIPLE
Status: COMPLETED
Enrollment: 31
Start: 2011-10-25
Primary completion: 2012-02-18
Lead sponsor: Merck Sharp & Dohme LLC
Conditions: Hypertension
Interventions: DRUG:MK-8457; DRUG:Placebo for MK-8457
Results posted: TRUE
Individual participant data sharing: YES

Registered primary outcomes

Change From Baseline to Day 10 in 24-hour Mean Ambulatory Systolic Blood Pressure (SBP) [Baseline and Day 10]
Number of Participants Who Experienced at Least One Adverse Event (AE) [Up to 70 days]
Number of Participants Who Discontinued the Study Medication Due to an AE [Up to 70 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.